Press release
Transthyretin Amyloid Cardiomyopathy Treatment Market Deep Research Report - Pfizer, Ionis Pharmaceuticals
Transthyretin Amyloid Cardiomyopathy Treatment Market InsightsTransthyretin Amyloid Cardiomyopathy Treatment Market is estimated to be valued at USD 2.91 Bn in 2025 and is expected to reach USD 19.37 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 31.1% from 2025 to 2032.
Coherent Market Insights has published a new comprehensive analysis on the Transthyretin Amyloid Cardiomyopathy Treatment Market (2025-2032), focusing on critical transformations in the U.S. healthcare environment. This report highlights essential metrics including market size, revenue forecasts, CAGR, adoption trends, and regulatory drivers. Backed by clinical evidence and real-world data, the study equips stakeholders with reliable guidance on technology adoption, value-based care models, and healthcare digitization.
π‘Request a Sample of the US Tariff Impact Analysis Report Today: - https://www.coherentmarketinsights.com/insight/request-sample/4321
π Strategic View of the Evolving Market
This report explores the current landscape and future outlook of the U.S. Transthyretin Amyloid Cardiomyopathy Treatment Market through segmented views by therapy area, care setting, and payer models. Designed for decision-makers, it combines primary research with data from leading authorities to evaluate technological innovation, policy shifts, and investment potential. Healthcare executives, investors, and providers can leverage this data for tactical and strategic planning across clinical and administrative domains.
π₯ Featured Market Leaders:
β Pfizer Inc.
β GlaxoSmithKline Plc.
β Eidos Therapeutics
β Ionis Pharmaceuticals Inc.
β Alnylam Pharmaceuticals
β Prothena Corporation plc
β Intellia Therapeutics Inc.
β Corino Therapeutics Inc.
π Transthyretin Amyloid Cardiomyopathy Treatment Market Segmentation Highlights:
By Type: Hereditary Transthyretin Amyloidosis (hATTR), Wild Type Transthyretin Amyloidosis (wtATTR)
By Drug Type: Transthyretin Stabilizers, Nonsteroidal Anti-Inflammatory Drugs (NSAID), RNAi Therapy, Others
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
π β Make Smarter Decisions - Buy the US Tariff Impact Analysis Report : https://www.coherentmarketinsights.com/insight/buy-now/4321
π Transthyretin Amyloid Cardiomyopathy Treatment Market Distribution
Gain insights into regional and country-level performance of the Transthyretin Amyloid Cardiomyopathy Treatment Market, with a breakdown across major healthcare regions:
North America: U.S., Canada, Mexico
Europe: U.K., Germany, France, Italy, Spain, Rest of Europe
Asia-Pacific: China, Japan, India, Australia, Rest of APAC
South America: Brazil, Argentina, Rest of SA
Middle East & Africa: UAE, Saudi Arabia, South Africa, Rest of MEA
π Transthyretin Amyloid Cardiomyopathy Treatment Market Dynamics
Rising prevalence of transthyretin amyloid cardiomyopathy
Advancements in RNA interference therapies
Increasing awareness and diagnosis rates
π― Why Choose This Report?
Market Leadership: Benchmark top competitors and rising innovators in digital health and biotech.
Investment Insight: Identify clinical areas with growth potential and assess reimbursement alignment.
Strategic Foresight: Understand healthcare reform impacts and emerging care delivery models.
Presentation-Ready Data: Use expertly designed graphics and validated insights for internal briefings.
The research combines interviews with providers, hospital executives, and policy analysts, supported by data from CDC, CMS, WHO, and leading journals. The methodology includes triangulated forecasting for robust and reliable insights.
π Report Table of Contents (2025-2032)
(1) Executive Summary
(2) Market Landscape Overview
(3) Therapeutic Segmentation
(4) Care Model & Reimbursement Trends
(5) Technology and Innovation Pipeline
(6) Regional and Country Analysis
(7) Competitive Landscape
(8) Regulatory and Policy Review
(9) Future Outlook and Strategic Recommendations
ποΈ β Make Smarter Decisions - Buy the US Tariff Impact Analysis Report : https://www.coherentmarketinsights.com/insight/buy-now/4321
Read More Trending Articles
Portable Medical Devices Market - https://www.globenewswire.com/en/news-release/2023/06/30/2697785/0/en/Portable-Medical-Devices-Market-Size-to-Surpass-US-148-7-Billion-by-2030-Report-by-Coherent-Market-Insights.html
Biosurgery Market - https://www.globenewswire.com/news-release/2023/06/30/2697894/0/en/Global-Biosurgery-Market-to-Reach-US-22-21-Billion-by-2028-Says-Coherent-Market-Insights.html
Patient Mechanical Lift Handling Equipment Market - https://www.globenewswire.com/news-release/2023/07/04/2698996/0/en/Patient-Mechanical-Lift-Handling-Equipment-Market-to-Reach-US-3-140-6-Million-by-2030-Coherent-Market-Insights-Inc.html
Crispr Technology Market - https://www.globenewswire.com/news-release/2023/07/11/2702988/0/en/CRISPR-Technology-Market-to-Reach-US-7-72-Billion-by-2030-Coherent-Market-Insights.html
Spatial Omics Market - https://www.globenewswire.com/news-release/2023/07/12/2703483/0/en/Global-Spatial-OMICS-Market-to-Reach-547-Million-by-2030-at-9-4-CAGR-Coherent-Market-Insights.html
β Frequently Asked Questions
(1) What are the key factors driving Transthyretin Amyloid Cardiomyopathy Treatment Market growth from 2025-2032?
(2) Which healthcare organizations are leading innovation in the U.S.?
(3) How are AI, remote care, and digital therapeutics transforming treatment delivery?
(4) What regulatory changes will impact reimbursement and access to care?
(5) What CAGR is projected through 2032 for the U.S. healthcare sector?
ποΈ Authored by:
Alice Mutum brings over 7 years of expertise in healthcare journalism and data-driven content development. Her deep industry knowledge ensures that every publication is both scientifically accurate and strategically aligned for healthcare professionals.
About Coherent Market Insights
Coherent Market Insights is a trusted provider of Transthyretin Amyloid Cardiomyopathy Treatment Market intelligence and strategic consulting services. Our expertise spans pharmaceuticals, diagnostics, medtech, and digital health, offering forward-looking insights for business development, policy alignment, and care delivery optimization. We operate globally with offices in the U.S., U.K., India, and Japan.
π Contact Information:
Mr. Shah
Senior Client Partner - Business Development
Coherent Market Insights
π US: +1-252-477-1362
π UK: +44-203-957-8553
π AUS: +61-2-4786-0457
π India: +91-848-285-0837
β Email: sales@coherentmarketinsights.com
π Website: www.coherentmarketinsights.com
Follow us: LinkedIn | Twitter
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Transthyretin Amyloid Cardiomyopathy Treatment Market Deep Research Report - Pfizer, Ionis Pharmaceuticals here
News-ID: 4043055 • Views: β¦
More Releases from Coherent Market Insights

Future-Proofing Growth of Offshore Wind Power Market: Is Booming So Rapidly with β¦
The offshore wind power market is poised for significant growth as countries around the world increasingly turn to renewable energy sources to meet their power needs and combat climate change. With advancements in technology and a favorable regulatory environment, the offshore wind sector is becoming an integral part of the global energy mix. The Global Offshore Wind Power Market size is estimated to be valued at USD 50 billion inβ¦

Protocol Analyzer Market Unveiling the Future | Global Market Insights, Trends & β¦
The Protocol Analyzer market is estimated to be valued at USD 4.64 Bn in 2025 and is expected to reach USD 10.65 Bn by 2032, growing at a compound annual growth rate CAGR of 12.6% from 2025 to 2032.
β€ The latest report published by Coherent Market Insights highlights the growth prospects of the Protocol Analyzer Market from 2025 to 2032. In-depth research on Industry Size, Share, Business Analysis, Growth Factors,β¦

Home Shopping Services Market is Going to Boom: Strategic Insights and Growth Op β¦
The Home Shopping Services market is estimated to be valued at USD 6.73 Bn in 2025 and is expected to reach USD 19.96 Bn by 2032, growing at a compound annual growth rate CAGR of 16.8% from 2025 to 2032.
β€ The Home Shopping Services Market Research Report covers a wide range of aspects, such as industry growth, revenue, development, segments, companies and progress, main trends, market dynamics, challenges, standards, deploymentβ¦

Antibodies Contract Manufacturing Market Set for Dynamic Boom as Key Players Amg β¦
The Antibodies Contract Manufacturing market is estimated to be valued at USD 21.61 Bn in 2025 and is expected to reach USD 42.68 Bn by 2032, growing at a compound annual growth rate CAGR of 10.2% from 2025 to 2032.
β€ The latest report "Antibodies Contract Manufacturing 2025 by Key Players, Regions, Types and Applications, Forecast to 2032" from Coherent Market Insights provides a detailed and comprehensive analysis of the Antibodiesβ¦
More Releases for Transthyretin
Evolving Market Trends In The Transthyretin Amyloidosis Treatment Industry: Inno β¦
The Transthyretin Amyloidosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Transthyretin Amyloidosis Treatment Market Size During the Forecast Period?
The market for transthyretin amyloidosis treatments has witnessed significant growth in the past few years. The market, which was valued atβ¦
What's Driving the Transthyretin Amyloidosis Treatment Market 2025-2034: Increas β¦
What Are the Projections for the Size and Growth Rate of the Transthyretin Amyloidosis Treatment Market?
The market for transthyretin amyloidosis treatment has seen robust growth in the past years. Its size is forecasted to increase from $5.52 billion in 2024 to $5.95 billion in 2025, with a compound annual growth rate (CAGR) of 7.8%. The surge in the market over the historic period is due to increased disease awareness, progressβ¦
Transthyretin Amyloid Cardiomyopathy Market Statistical Forecast, Trade Analysis β¦
DataM Intelligence has published a new research report on "Transthyretin Amyloid Cardiomyopathy Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample Research PDFβ¦
Unveiling Transthyretin Amyloidosis Treatment Market 2024
The transthyretin amyloidosis treatment market size has grown strongly in recent years. It will grow from $5.07 billion in 2023 to $5.52 billion in 2024 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increased disease awareness, advancements in diagnostic tools, drug development and approvals, patient advocacy and support, collaboration in research..
The transthyretin amyloidosis treatment market size isβ¦
Transthyretin Amyloidosis (ATTR) Market 2022 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the Transthyretin Amyloidosis (ATTR) market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading playersβ performance based on revenue generation and client requirements. Also, the research report revealsβ¦
Anti-Transthyretin Global Market Research Report 2025
Anti-Transthyretin Report by Material, Application, and Geography οΏ½ Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
Access more details about this report at: https://www.research2reports.com/report-medical-devices/anti-transthyretin-market/80994
The report firstly introduced the Anti-Transthyretin basics: definitions, classifications, applications and market overview;β¦